During the past decade, Andreas Kupsch conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Andreas Kupsch" #1 collaborator was "Heinrich-Heine University, Duesseldorf" with 1 trials as a collaborator, "Humboldt-Universität zu Berlin" with 1 trials as a collaborator, "Ludwig-Maximilians - University of Munich" with 1 trials as a collaborator, "Medical University Innsbruck" with 1 trials as a collaborator and "Medical University of Cologne" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Andreas Kupsch" are "Dystonia" (1 trials), "Migraine Disorders" (1 trials) and "Movement Disorder" (1 trials). Many other conditions were trialed in "Andreas Kupsch" in a lesser frequency.

Most popular intervention types in "Andreas Kupsch" are "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "botulinum toxin Type A" (1 trials) and "deep brain stimulation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Andreas Kupsch" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Andreas Kupsch". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Andreas Kupsch, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Andreas Kupsch, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".